2) HIRAMATSU, K.; H. HANAKI, T. INO, K. YABUTA, T. OGURI & F. C. TENOVER: Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J. Antimicrob. Chemother. 40: 135-136, 1997
3) HANAKI, H. & K. HIRAMATSU: Evaluation of reduced vancomycin susceptibility of MRSA strains Mu50 with various conditions of antibiotics susceptibility tests. Jpn. J. Antibiotics 50: 794-798, 1997
4) HANAKI, H.; H. LABISCHINSKI, K. SASAKI, K. KUWAHARA, Y. INABA & K. HIRAMATSU: Mechanism of vancomycin resistance in MRSA strain Mu50. Jpn. J. Antibiotics 51: 237-247, 1998
5) HANAKI, H.; H. LABISCHINSKI, Y. INABA & K. HIRAMATSU: Increase of non-amidated muropeptides in the cell wall of vancomycin-resistant Staphylococcus aureus (VRSA) strain Mu50. Jpn. J. Antibiotics 51: 272-280, 1998